J Urol. 1997 Jul;158(1):31-3.

Protease inhibitors and urolithiasis.

Sutherland SE, Reigle MD, Seftel AD, Resnick MI.

Source

Department of Urology, Case Western Reserve University, Cleveland, Ohio, USA.

Abstract

PURPOSE:

We discuss the specific urological abnormalities associated with protease inhibitor therapy.

MATERIALS AND METHODS:

We report on a human immunodeficiency virus positive patient who was on protease inhibitor therapy and presented with renal colic.

RESULTS:

The stone passed spontaneously. Stone analysis was not consistent with any known composition of urinary calculus.

CONCLUSIONS:

The positive effects of protease inhibitors in human immunodeficiency virus positive patients mandate that the urological community become familiar with these drugs and the specific urological complications as the use of these drugs becomes widespread.

PMID:: 9186316; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

HIV/AIDS Medicines - MedlinePlus Health Information

Supplemental Content

Related citations

Protease inhibitor-induced urolithiasis. [Urology. 1997]
Protease inhibitor-induced urolithiasis.
Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF. Urology. 1997 Oct; 50(4):508-11.
Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients. [Int Urol Nephrol. 2002]
Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients.
Kalaitzis C, Dimitriadis G, Tsatidis T, Kuntz R, Touloupidis S, Kelidis G. Int Urol Nephrol. 2002; 34(1):13-5.
Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus. [J Urol. 1999]
Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
Kohan AD, Armenakas NA, Fracchia JA. J Urol. 1999 Jun; 161(6):1765-8.
Review Renal toxicity of protease inhibitors. [Curr Opin Nephrol Hypertens. 2000]
Review Renal toxicity of protease inhibitors.
Olyaei AJ, deMattos AM, Bennett WM. Curr Opin Nephrol Hypertens. 2000 Sep; 9(5):473-6.
Review [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases]. [J Urol (Paris). 1997]
Review [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
Chefchaouni MC, Thiounn N, Flam T, Zerbib M, Debré B. J Urol (Paris). 1997; 103(1-2):35-6.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Protease inhibitors and urolithiasis.
Protease inhibitors and urolithiasis.
J Urol. 1997 Jul ;158(1):31-3.

PubMed
Sentography: dynamic forms of communication of emotion and qualities.
Sentography: dynamic forms of communication of emotion and qualities.
Comput Biol Med. 1973 Sep ;3(2):119-30.

PubMed
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the t...
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Clin Infect Dis. 1996 May ;22(5):813-8.

PubMed
Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose ...
Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
Drug Metab Dispos. 1996 Dec ;24(12):1389-94.

PubMed
Differential pattern of the circadian rhythm of serum melatonin in young and eld...
Differential pattern of the circadian rhythm of serum melatonin in young and elderly healthy subjects.
Biol Signals. 1997 Jul-Dec ;6(4-6):301-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: